Differences in the outcomes and complications between elderly and younger uterine cervical cancer patients treated by definitive radiotherapy — A propensity score-matched study
Yu‐Ming Wang, Chong‐Jong Wang, Fu‐Min Fang et al. · Gynecologic Oncology · 2017
Cited by 38 works. doi:10.1016/j.ygyno.2017.02.034
Authors
- Yu‐Ming Wang
- Chong‐Jong Wang
- Fu‐Min Fang
- Hui‐Chun Chen
- Hsuan‐Chih Hsu
- Yu-Jie Huang
- Changyu Wang
- Eng‐Yen Huang
References
- Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European organization for research and treatment of cancer (EORTC)
- Radical Prostatectomy versus Watchful Waiting in Early Prostate Cancer
- Concurrent Cisplatin-Based Radiotherapy and Chemotherapy for Locally Advanced Cervical Cancer
- Radical Prostatectomy versus Watchful Waiting in Early Prostate Cancer
- Cisplatin, Radiation, and Adjuvant Hysterectomy Compared with Radiation and Adjuvant Hysterectomy for Bulky Stage IB Cervical Carcinoma
- Cellular senescence: when bad things happen to good cells
- Radiation therapy alone in the treatment of carcinoma of the uterine cervix. II. Analysis of complications
- Clinical Outcomes of Definitive Intensity-Modulated Radiation Therapy With Fluorodeoxyglucose–Positron Emission Tomography Simulation in Patients With Locally Advanced Cervical Cancer
- Radiation therapy with or without weekly cisplatin for bulky stage 1B cervical carcinoma: follow-up of a Gynecologic Oncology Group trial
- Cervical carcinoma in the elderly